Evan Gomes
Impact in
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cell death mechanisms and regulation 4
- Ubiquitin and proteasome pathways 2
- Angiogenesis and VEGF in Cancer 1
- Mitochondrial Function and Pathology 1
- Histone Deacetylase Inhibitors Research 1
- Cancer therapeutics and mechanisms 1
- Oncology 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Patricia Rockwell (4 shared papers)William H. Gmeiner (4 shared papers)David Carroll (1 shared paper)John D. Olson (1 shared paper)Martin Guthold (1 shared paper)Supratim Ghosh (1 shared paper)Samrat Dutta (1 shared paper)Ralph B. D’Agostino (1 shared paper)
- Journals
- Blood (2 papers)Journal of Clinical Oncology (1 paper)ACS Nano (1 paper)FEBS Letters (1 paper)Molecular and Cellular Biochemistry (1 paper)
- Partner nations
- United StatesRussia
In The Last Decade
Evan Gomes
10 papers receiving 380 citations
Peers
Comparison fields: 5 of 65
- Biomedical Engineering 165
- Biomaterials 47
- Materials Chemistry 116
- Molecular Biology 145
- Cancer Research 28
Countries citing papers authored by Evan Gomes
This map shows the geographic impact of Evan Gomes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Gomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Gomes more than expected).
Fields of papers citing papers by Evan Gomes
This network shows the impact of papers produced by Evan Gomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Gomes. The network helps show where Evan Gomes may publish in the future.
Co-authors
The 22 scholars most cited alongside Evan Gomes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 199 | |
| 2 | 2007 | 48 | |
| 3 | 2012 | 40 | |
| 4 | 2007 | 29 | |
| 5 | 2008 | 27 | |
| 6 | 2006 | 24 | |
| 7 | 2012 | 9 | |
| 8 | 2011 | 5 | |
| 9 | 2010 | 1 | |
| 10 | 2013 | 1 |
About Evan Gomes
Evan Gomes is a scholar working on Molecular Biology, Oncology, Hematology, Cell Biology and Pharmacology, having authored 10 papers that have together received 383 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Acute Myeloid Leukemia Research (2 papers), Ubiquitin and proteasome pathways (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Mitochondrial Function and Pathology (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Cancer therapeutics and mechanisms (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Biomedical Engineering (165 citations), Biomaterials (47 citations), Materials Chemistry (116 citations), Molecular Biology (145 citations) and Cancer Research (28 citations). Evan Gomes has collaborated with scholars based in United States and Russia. Frequent co-authors include Patricia Rockwell, William H. Gmeiner, David Carroll, John D. Olson, Martin Guthold, Supratim Ghosh, Samrat Dutta, Ralph B. D’Agostino, Luena Papa and Jamie Jennings‐Gee. Their work appears in journals such as Blood, Journal of Clinical Oncology, ACS Nano, FEBS Letters and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.